Increase in cancer screening may be result of ACA provision
the ONA take:
According to a new study published online in the journal Cancer, researchers from the American Cancer Society have found that colorectal cancer screening increased in individuals of lower socioeconomic status after 2008, potentially as a result of a provision in the Affordable Care Act that removed financial barriers to preventive services, including breast and colorectal cancer screening.
For the study, researchers analyzed data from the National Health Interview Survey to compare breast cancer and colorectal cancer screening prevalence among individuals with private and Medicare insurance by socioeconomic status before and after the Affordable Care Act was enacted.
Results showed that colorectal cancer screening increased from 57.3% to 61.2% between 2008 and 2013. The increase in screening prevalence was apparent in least-educated, low-income, and Medicare-insured patients, but not among those in higher socioeconomic groups.
The researchers also found a significant increase in colorectal cancer screening among Medicare-insured and privately insured individuals across all socioeconomic levels.
There was no increase in breast cancer screening between 2008 and 2013, possibly due to fewer barriers because of lower cost, women's health initiatives, and the already higher prevalence of breast cancer screening prevalence compared with colorectal cancer screening.
Affordable Care Act has removed financial barriers to preventive services, including breast and colorectal cancer screening.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|